Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.5697
-0.0293 (-4.89%)
At close: Sep 9, 2026, 4:00 PM EDT
0.5496
-0.0201 (-3.53%)
After-hours: Sep 9, 2026, 4:23 PM EDT
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $19.04 million as of September 9, 2026. Its market cap has increased by 232.00% in one year.
Market Cap
19.04M
Enterprise Value
-26.63M
1-Year Change
232.00%
Ranking
Category
Stock Price
$0.57
ChartMarket Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $19.04M, a decrease of -70.84%. That is a compound annual growth rate of -21.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 19.04M | -36.09% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akari Therapeutics, | 21.34M |
| Longeveron | 21.20M |
| Polyrizon | 20.87M |
| Palatin Technologies | 20.68M |
| Cerenome | 20.49M |
| Neuphoria Therapeutics | 20.27M |
| Chemomab Therapeutics | 19.93M |
| Allarity Therapeutics | 19.89M |